Details for New Drug Application (NDA): 073398
✉ Email this page to a colleague
The generic ingredient in K-LEASE is potassium chloride. There are two hundred and forty drug master file entries for this compound. Eighty-nine suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
Summary for 073398
Tradename: | K-LEASE |
Applicant: | Savage Labs |
Ingredient: | potassium chloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 8MEQ | ||||
Approval Date: | Jan 28, 1992 | TE: | RLD: | No |
Complete Access Available with Subscription